Researchers at Sydney’s Centenary Institute fight against hepatitis infection

Today is World Hepatitis Day. 400 million people around the world are currently living with hepatitis B or C. Each year, we see around 1.4 million people die from viral hepatitis. Researchers at Sydney’s Centenary Institute are working hard to change this.

By improving our understanding of the mechanisms that drive hepatitis, Centenary Institute scientists are working to uncover new ways to treat and prevent the disease. This could save around 4,000 lives each day.

Head of the Liver Injury & Cancer Program at the Centenary Institute, Professor Geoff McCaughan, said the key to fighting hepatitis is to understand it.

“There is currently no vaccination to prevent hepatitis C, and some people don’t respond well to the treatments currently available,” Professor McCaughan said.

“We know that the key mechanism driving hepatitis is inflammation. At the Centenary Institute, we are working to better understand, control and target inflammation, as a means of preventing and treating liver disease.

“If left untreated, hepatitis can lead to liver failure and liver cancer. It is a truly insidious disease and we are determined to tackle it.”

Viral hepatitis is inflammation of the liver caused by a virus. There are five different hepatitis viruses (hepatitis A, B, C, D and E). Researchers at the Centenary Institute currently have projects specifically looking at Hepatitis B and C. At RPA our researchers lead by Professor McCaughan are endeavouring to turn around patients from the brink of liver transplantation by administering new anti-HCV therapies to patients with HCV related liver failure .Early results are promising with a significant number patients showing reversibility thus potentially decreasing the need for transplantation. Results of this work have been submitted to major national and International meetings and will be presented in late 2015.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Cardiovascular risks of COVID-19 antivirals